Veterinary Healthcare Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

Coverage: Veterinary Healthcare Market covers analysis By Product (Veterinary Services, Veterinary Medical Equipment, Veterinary Medicines, Others); Application (Companion Animals, Livestock Animals, Others); End User (Veterinary Hospitals, Veterinary Clinics, Others) , and Geography (North America, Europe, Asia Pacific, and South and Central America)

  • Report Code : TIPRE00019343
  • Category : Life Sciences
  • Status : Upcoming
  • No. of Pages : 150
Buy Now

MARKET INTRODUCTION



Veterinary healthcare is the act of protecting & curing animals of various diseases using vaccines & other treatments and also providing them veterinary services to expand their lifespan & yield. It includes veterinary services, animal medicine, and veterinary medical equipment. Veterinary medicine is defined as the science associated with the diagnosis, treatment, and prevention of diseases in animals. Besides, the increasing importance of the production of livestock animals is generating growth in the veterinary healthcare market.

MARKET DYNAMICS



The veterinary healthcare market has shown a significant evolution over the forecast period. The rise of the veterinary healthcare market is driven by the increasing incidence of zoonotic diseases, rising awareness towards animal health, technological advancements in animal healthcare diagnostics, and increasing government initiatives from the global veterinary medical association. Moreover, the growth in the pet population, increasing penetration of pet insurance, pet humanization within the growing global urban population, and increased awareness of animal welfare needs due to social media are helping the veterinary industry to maintain growth at 6.2% a year. Increased awareness of preventative care and specialty services availability has created a higher demand for both routine and more sophisticated procedures. However, high costs of veterinary services and animal testing, lack of infrastructure and funding, and use of counterfeit medicines are hindering the growth of the veterinary healthcare market globally.

MARKET SCOPE



The "Veterinary Healthcare Market Analysis to 2031" is a specialized and in-depth study of the healthcare industry's pharmaceuticals, focusing on the global market trend analysis. This report outlines the veterinary healthcare market with detailed market segmentation by product, application, and end-user. The veterinary healthcare market is estimated to witness a high rise during the forecast period. It focuses on the vital statistics on leading players' market status in the veterinary healthcare market and provides key opportunities and trends in the market.

MARKET SEGMENTATION



The market is categorized based on the product, application, and end user. Based on the product, the market is segmented as veterinary services, veterinary medical equipment, veterinary medicines, and others. Based on the application, the segmentation of the market is into companion animals, livestock animals, and others. Based on end user, the segmentation of the market is into veterinary hospitals, veterinary clinics, and others.

REGIONAL FRAMEWORK



The report states a detailed outline of the industry, consisting of both quantitative and qualitative information. It offers a sketch and forecast of the veterinary healthcare market based on various segments. The report also consists of market size and forecast estimates from the year 2021 to2031with respect to five main regions, namely; North America, Asia-Pacific (APAC), Europe, Middle East, and Africa (MEA), and South & Central America (SCAM). The veterinary healthcare market by each region is then sub-segmented into respective countries and segments. It comprises the analysis and forecast of 18 countries globally and the recent trend and opportunities prevailing in the region.

The report analyzes factors affecting the veterinary healthcare market from both the demand and supply sides. Furthermore, it evaluates market dynamics regarding the market during the forecast period, i.e., drivers, restraints, opportunities, and future trends. It also consists of precise PEST analysis for all five regions, namely, North America, Asia Pacific, Europe, Middle East, and Africa, and South & Central America, after assessing political, social, economic, and technological factors affecting the veterinary healthcare market in these regions.

MARKET PLAYERS



The report contains critical developments in the veterinary healthcare market as inorganic and organic growth strategies. Several companies are pivoting on organic growth strategies like product launches, product approvals, and others, such as patents and events. Inorganic growth strategies observed were collaborations and acquisitions &partnerships. Various such activities have paved the path for elaborating the business and customer base of market players. The market players from the veterinary healthcare market are estimated to have profitable growth opportunities in the coming years with the higher demand for veterinary healthcare in the global market. Given below is the list of a few companies engaged in the veterinary healthcare market.

The report also offers key players' profiles in the veterinary healthcare market, along with their SWOT analysis and market strategies. Also, the report focuses on the key market players with information on company profiles, financial information of the last three years, components, and services provided, critical development in the past five years.

  •  Zoetis
  •  Boehringer Ingelheim International GmbH
  •  Bayer AG
  •  Eli Lilly and Company.
  •  Ceva
  •  Dechra Pharmaceuticals PLC.
  •  Intervet Inc. (Merck & Co. Inc.)
  •  Virbac.
  •  Vetoquinol S.A.
  •  Evonik Industries AG.

The Insight Partner's dedicated research and the analytical team comprises of experienced professionals with advanced statistical expertise and offers several customization options in the current report.

Veterinary Healthcare Report Scope

Report Attribute Details
Market size in 2023 US$ XX Million
Market Size by 2031 US$ XX Million
Global CAGR (2023 - 2031) XX%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Product
  • Veterinary Services
  • Veterinary Medical Equipment
  • Veterinary Medicines
By Application
  • Companion Animals
  • Livestock Animals
By End User
  • Veterinary Hospitals
  • Veterinary Clinics
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Zoetis
  • Boehringer Ingelheim International GmbH
  • Bayer AG
  • Eli Lilly and Company.
  • Ceva
  • Dechra Pharmaceuticals PLC.
  • Intervet Inc. (Merck & Co. Inc.)
  • Virbac.
  • Vetoquinol S.A.
    • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
    • PEST and SWOT Analysis
    • Market Size Value / Volume - Global, Regional, Country
    • Industry and Competitive Landscape
    • Excel Dataset
    Report Coverage

    Report Coverage

    Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

    Segment Covered

    Segment Covered

    This text is related
    to segments covered.

    Regional Scope

    Regional Scope

    North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

    Country Scope

    Country Scope

    This text is related
    to country scope.

    Trends and growth analysis reports related to Life Sciences : READ MORE..   

    The List of Companies

    1.Zoetis
    2.Boehringer Ingelheim International GmbH
    3.Bayer AG
    4.Eli Lilly and Company.
    5.Ceva
    6.Dechra Pharmaceuticals PLC.
    7.Intervet Inc. (Merck & Co. Inc.)
    8.Virbac.
    9.Vetoquinol S.A.
    10.Evonik Industries AG.

    Buy Now